|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
35.480 +2.400 (+7.255%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 2,758,000 | -1.667% | 2,804,765 | 3,045,060 | 3,195,646 | 3,224,555 |
| Land & other Lease Assets | 421,344 | -4.761% | 442,405 | 234,663 | 254,247 | 250,840 |
| Intangible Assets | 362,647 | 47.847% | 245,286 | 177,416 | 33,422 | 17,037 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 241,071 | 0 |
| Other Non-current Assets | 803,018 | 10.976% | 723,598 | 698,633 | 445,873 | 488,371 |
| 4,345,009 | 3.059% | 4,216,054 | 4,155,772 | 4,170,259 | 3,980,803 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | 608,922 | -6.496% | 651,224 | 575,782 | 447,890 | 410,127 | |
| Trade Receivables | 3,060,517 | -3.447% | 3,169,763 | 3,214,251 | 3,578,392 | 3,675,990 | |
| Cash & Bank Balances | 31,548,668 | 39.463% | 22,621,566 | 22,434,691 | 17,615,274 | 14,702,056 | |
| Other Current Assets | 337,235 | -66.251% | 999,242 | 2,658,583 | 4,190,064 | 4,391,195 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 35,555,342 | 29.566% | 27,441,795 | 28,883,307 | 25,831,620 | 23,179,368 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | 334,314 | 53.460% | 217,851 | 163,763 | 222,296 | 248,330 | ||
| S-T Debt & Leases | 57,469 | 1.036% | 56,880 | 4,199,285 | 15,543 | 9,968 | ||
| Other Current Liabilities | 4,003,151 | 65.386% | 2,420,487 | 2,499,801 | 2,381,663 | 2,765,432 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 4,394,934 | 63.064% | 2,695,218 | 6,862,849 | 2,619,502 | 3,023,730 | |||
| Net Current Assets | 31,160,408 | 25.918% | 24,746,577 | 22,020,458 | 23,212,118 | 20,155,638 | ||
| Total Assets Less Current Liabilities | 35,505,417 | 22.590% | 28,962,631 | 26,176,230 | 27,382,377 | 24,136,441 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | 47,624 | -21.945% | 61,013 | 104,450 | 4,362,313 | 3,817,913 | |||
| Other Non-current Liabilities | 93,342 | -57.898% | 221,704 | 277,007 | 373,120 | 289,683 | |||
| 140,966 | -50.139% | 282,717 | 381,457 | 4,735,433 | 4,107,596 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | 53 | 1.923% | 52 | 52 | 52 | 52 | ||||
| Reserves | 35,364,398 | 23.307% | 28,679,862 | 25,794,721 | 22,646,892 | 20,028,793 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 35,364,451 | 23.307% | 28,679,914 | 25,794,773 | 22,646,944 | 20,028,845 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 35,364,451 | 23.307% | 28,679,914 | 25,794,773 | 22,646,944 | 20,028,845 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 326,242 | 80,445 | 39,341 | 202,836 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 31/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,555,461 |
| %Change | 27.074% |
| EPS / (LPS) | RMB 0.930 |
| NBV Per Share (¥) | RMB 5.840 |